The Provider Perspective: Identifying Barriers to Prescribing Long Acting Injectables to Persons with Mental Illness
College of Health Sciences
D.N.P. Nursing Practice - Advanced Practice
Long acting injectable (LAI) antipsychotic medications should be used as a first-line treatment when patients require long-term antipsychotic treatment. However, clinicians often decide not to prescribe these drugs. Psychiatric clinicians are positioned to create and employ change. Therefore, it is important to explore experiences and opinions influencing LAI antipsychotic medication prescribing practices to minimize barriers that impact the receipt of the best and most appropriate medications for persons with mental illnesses. This study will explore the relationship between provider sociodemographic, practice locations, behavior attitudes, industry norms, and clinician prescribing behaviors. A non-experimental cross-sectional design with prospective data collection as an anonymous on-line survey used to collect data. Identification of any correlations between the sociodemographic, contextual factors, behavior attitudes, subjective norms, perceived behavioral control, and prescribing behaviors of clinicians and plans to, or not, increase use of LAI antipsychotic medications in their practice in the following 12 months. LAI antipsychotic medications improve patient adherence to treatment, but clinicians often fail to prescribe these drugs. Providers are central to successful patient outcomes as they control which medications are prescribed. Therefore, it is critical to explore factors that influence clinicians’ decisions to prescribe LAI antipsychotic medications, creating a barrier for patient accessibility.
Farley, Kimberly and Zimbro, Kathie S., "The Provider Perspective: Identifying Barriers to Prescribing Long Acting Injectables to Persons with Mental Illness" (2019). College of Health Sciences Posters. 13.